Resources | NITAG RESOURCE CENTER

2024 ∙ NACI

Guidance on an additional dose of COVID-19 vaccines in the spring for individuals at high risk of severe illness due to COVID-19

2023 ∙ Alhandod, T. A. Rabbani, S. I. Almuqbil, M. Alshehri, S. Hussain, S. A. Alomar, N. F. Mir, M. A. Asdaq, S. M. B.

A Systematic Review on the Safety and Efficacy of COVID-19 Vaccines Approved in Saudi Arabia

2023 ∙ Xiao, Hong Vaidya, Riha Liu, Fang Chang, Ximing Xia, Xiaoqian Unger, Joseph M.

Sex, Racial, and Ethnic Representation in COVID-19 Clinical Trials: A Systematic Review and Meta-analysis

2023 ∙ Masaquel, C. Schley, K. Wright, K. Mauskopf, J. Parrish, R. A. Presa, J. V. Hewlett, D.

The Impact of Social Determinants of Health on Meningococcal Vaccination Awareness, Delivery, and Coverage in Adolescents and Young Adults in the United States: A Systematic Review

2023 ∙ Wang, Qiang Yang, Liuqing Li, Lan Liu, Chang Jin, Hui Lin, Leesa

Willingness to Vaccinate Against Herpes Zoster and Its Associated Factors Across WHO Regions: Global Systematic Review and Meta-Analysis

2023 ∙ Matthew Tunis, Shelley Deeks, Caroline Quach, Marina Salvadori, Bryna Warshawsky, Kelsey Young, Shainoor Ismail, Christine Mauviel, Erin Henry

Canada’s National Advisory Committee on immunization: Adaptations and challenges during the COVID-19 pandemic

2023 ∙ CAVEI

CAVEI recommendation on incorporation of a monoclonal antibody for passive immunization against respiratory syncytial virus in infants in the Program National Immunization

2023 ∙ CAVEI

CAVEI RECOMMENDATION ON VACCINATION INCORPORATION AGAINST RESPIRATORY SYNCYCIAL VIRUS IN OLDER ADULTS AND PREGNANT WOMEN IN THE NATIONAL IMMUNIZATION PROGRAM

2023 ∙ CAVEI

update of the CAVEI recommendation on vaccination against HPV

2023 ∙ CAVEI

CAVEI recommendation on updating the vaccination strategy against COVID-19 by 2024